Document Details

Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Diffusion Pharmaceuticals Inc. (Charlottesville, VA)
Event Date 12/13/2018
Filing Date 12/14/2018

Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; and Financial Statements and Exhibits.
Download

File Section(s)

  1. FORM 8-K
  2. EXHIBIT 3.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.